NK:IO

NK:IO Limited is a biotechnology company developing exceptionally effective off-the-shelf cell therapies for solid tumors. It aims to develop new approaches to natural killer (NK) cell-mediated immunotherapy. The company develops cell therapies and small molecule therapies primarily targeting cancer, enabling doctors to target cancer more effectively.